======= SPR ======= == Gene Information == * **Official Symbol**: SPR * **Official Name**: sepiapterin reductase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6697|6697]] * **UniProt**: [[https://www.uniprot.org/uniprot/P35270|P35270]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SPR&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SPR|Open PubMed]] * **OMIM**: [[https://omim.org/entry/182125|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes an aldo-keto reductase that catalyzes the NADPH-dependent reduction of pteridine derivatives and is important in the biosynthesis of tetrahydrobiopterin (BH4). Mutations in this gene result in DOPA-responsive dystonia due to sepiaterin reductase deficiency. A pseudogene has been identified on chromosome 1. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Catalyzes the final one or two reductions in tetra- hydrobiopterin biosynthesis to form 5,6,7,8-tetrahydrobiopterin. |adh short| |sepiapterin reductase activity| |tetrahydrobiopterin metabolic process| |tetrahydrobiopterin biosynthetic process| |aldo-keto reductase (NADP) activity| |nitric oxide biosynthetic process| |pteridine-containing compound biosynthetic process| |nitric oxide metabolic process| |diol biosynthetic process| |reactive nitrogen species metabolic process| |diol metabolic process| |reactive oxygen species biosynthetic process| |pteridine-containing compound metabolic process| |NADP binding| |neurotransmitter biosynthetic process| |regulation of nitric-oxide synthase activity| |regulation of monooxygenase activity| |polyol biosynthetic process| |neurotransmitter metabolic process| |regulation of oxidoreductase activity| |polyol metabolic process| |reactive oxygen species metabolic process| |alcohol biosynthetic process| |coenzyme biosynthetic process| |organic hydroxy compound biosynthetic process| |cofactor biosynthetic process| |coenzyme metabolic process| |alcohol metabolic process| |regulation of neurotransmitter levels| |cofactor metabolic process| |organic hydroxy compound metabolic process| |drug metabolic process| |small molecule biosynthetic process| |oxidation-reduction process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |organonitrogen compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|-3.14| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-2.95| |[[:results:exp430|Rifampicin 30μM R08 exp430]]|-2.27| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|-2.07| |[[:results:exp182|IU1-47 25μM R04 exp182]]|-2.05| |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|-1.91| |[[:results:exp133|MKC9989 10μM R03 exp133]]|-1.89| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|-1.89| |[[:results:exp187|proTAME 5μM R04 exp187]]|-1.85| |[[:results:exp444|THZ531 0.225μM R08 exp444]]|-1.83| |[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|-1.81| |[[:results:exp457|Bisphenol F 50μM R08 exp457]]|-1.8| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|-1.79| |[[:results:exp512|Olaparib 4μM R08 exp512]]|-1.75| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|1.71| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|1.72| |[[:results:exp293|Myriocin 25μM R06 exp293]]|1.76| |[[:results:exp108|Vinblastine 0.2μM R03 exp108]]|1.76| |[[:results:exp447|Amiloride 100μM R08 exp447]]|1.77| |[[:results:exp507|Monensin 0.3μM R08 exp507]]|1.82| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|1.84| |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|1.85| ^Gene^Correlation^ |[[:human genes:p:pts|PTS]]|0.499| |[[:human genes:d:dhrsx|DHRSX]]|0.465| |[[:human genes:r:rnaseh2b|RNASEH2B]]|0.464| |[[:human genes:r:rpp21|RPP21]]|0.45| |[[:human genes:g:gtf3c6|GTF3C6]]|0.449| |[[:human genes:r:rabggtb|RABGGTB]]|0.43| |[[:human genes:a:alg1|ALG1]]|0.428| |[[:human genes:t:txnl4b|TXNL4B]]|0.422| |[[:human genes:t:thg1l|THG1L]]|0.414| |[[:human genes:v:vezt|VEZT]]|0.414| |[[:human genes:p:ppp6c|PPP6C]]|0.412| |[[:human genes:r:rnaseh2a|RNASEH2A]]|0.411| |[[:human genes:k:kdsr|KDSR]]|0.41| |[[:human genes:w:wdr1|WDR1]]|0.409| |[[:human genes:r:rad1|RAD1]]|0.409| |[[:human genes:r:rpe|RPE]]|0.403| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7721 * **Expression level (log2 read counts)**: 3.75 {{:chemogenomics:nalm6 dist.png?nolink |}}